Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFA14A
Source: 0001193125-25-087230
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFA14A
Chunk 2
---
Zevra, its directors,
executive officers, and employees may be deemed to be participants in the solicitation of proxies with respect to a solicitation by Zevra. Information about Zevra’s executive officers and directors is available under the heading
“Information about our Executive Officers and Directors” in Part I of Zevra’s
for the year ended
December 31, 2024, which was filed with the SEC on March 12, 2025 and under the headings “Proposal 1: Election of Directors,” “Executive Officers,” “Security Ownership of Certain Beneficial Owners and
Management” and “Executive Compensation,” and “Director Compensation” in Zevra’s
for its annual meeting of stockholders to be held in 2025,
which was filed with the SEC on April 21, 2025. To the extent holdings of our directors and executive officers of Zevra securities reported in such definitive proxy statement change, such changes will be reflected on Statements of Change in
Ownership on Forms 3, 4 or 5 filed with the SEC. These documents are available free of charge at the SEC’s website at . Copies of the documents are also available free of charge by accessing Zevra’s investor
relations website at .